These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22965852)

  • 41. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental drugs for bipolar psychosis.
    Fornaro M; Nardi AE; De Berardis D; Carta MG
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1371-1375. PubMed ID: 27802062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lithium treatment - the state of the art for 2020.
    Rybakowski J
    Psychiatr Pol; 2020 Dec; 54(6):1047-1066. PubMed ID: 33740796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
    Hahn CG; Friedman E
    Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.
    Smith LA; Cornelius V; Warnock A; Tacchi MJ; Taylor D
    Bipolar Disord; 2007 Sep; 9(6):551-60. PubMed ID: 17845269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug treatments for bipolar disorder: 1--Acute manic or depressive episodes.
    Drug Ther Bull; 2005 Apr; 43(4):28-32. PubMed ID: 15849974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gintonin stimulates gliotransmitter release in cortical primary astrocytes.
    Kim H; Lee BH; Choi SH; Kim HJ; Jung SW; Hwang SH; Rhim H; Kim HC; Cho IH; Nah SY
    Neurosci Lett; 2015 Aug; 603():19-24. PubMed ID: 26191656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lithium-pilocarpine seizures as a model for lithium action in mania.
    Belmaker RH; Bersudsky Y
    Neurosci Biobehav Rev; 2007; 31(6):843-9. PubMed ID: 17602744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic fluoxetine administration increases expression of the L-channel gene Cav1.2 in astrocytes from the brain of treated mice and in culture and augments K(+)-induced increase in [Ca(2+)]i.
    Du T; Liang C; Li B; Hertz L; Peng L
    Cell Calcium; 2014 Mar; 55(3):166-74. PubMed ID: 24513410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells.
    Pacheco MA; Jope RS
    Brain Res Mol Brain Res; 1999 Oct; 72(2):138-46. PubMed ID: 10529472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
    Bourin M; Prica C
    Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Employing pharmacologic treatment of bipolar disorder to greatest effect.
    Schatzberg AF
    J Clin Psychiatry; 2004; 65 Suppl 15():15-20. PubMed ID: 15554791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.